Business Description
Clover Biopharmaceuticals Ltd
ISIN : KYG2280A1076
Compare
Compare
Traded in other countries / regions
02197.Hong Kong IPO Date
2021-11-05Description
Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.29 | |||||
| Equity-to-Asset | -0.35 | |||||
| Debt-to-Equity | -0.46 | |||||
| Debt-to-EBITDA | -7.42 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 64.9 | |||||
| 3-Year Book Growth Rate | 15 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.74 | |||||
| 9-Day RSI | 66.83 | |||||
| 14-Day RSI | 62.18 | |||||
| 6-1 Month Momentum % | -52.6 | |||||
| 12-1 Month Momentum % | -77.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.83 | |||||
| Quick Ratio | 0.53 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 34848.3 | |||||
| Days Sales Outstanding | 114.77 | |||||
| Days Payable | 10932.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | -32.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.75 | |||||
| Operating Margin % | -2221.62 | |||||
| Net Margin % | -352.92 | |||||
| FCF Margin % | -1877.62 | |||||
| ROA % | -4.17 | |||||
| ROIC % | -39.38 | |||||
| ROC (Joel Greenblatt) % | -49.06 | |||||
| ROCE % | -14.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 0.31 | |||||
| PS Ratio | 13.09 | |||||
| EV-to-EBIT | -0.89 | |||||
| EV-to-Forward-EBIT | 0.02 | |||||
| EV-to-EBITDA | -2.36 | |||||
| EV-to-Forward-EBITDA | 0.01 | |||||
| EV-to-Revenue | 2.71 | |||||
| EV-to-FCF | -0.14 | |||||
| Earnings Yield (Greenblatt) % | -112.36 | |||||
| FCF Yield % | -139.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clover Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 42.936 | ||
| EPS (TTM) (HK$) | -0.12 | ||
| Beta | 0 | ||
| Volatility % | 57.09 | ||
| 14-Day RSI | 62.18 | ||
| 14-Day ATR (HK$) | 0.032584 | ||
| 20-Day SMA (HK$) | 0.3705 | ||
| 12-1 Month Momentum % | -77.61 | ||
| 52-Week Range (HK$) | 0.3 - 1.81 | ||
| Shares Outstanding (Mil) | 1,296.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clover Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clover Biopharmaceuticals Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clover Biopharmaceuticals Ltd Frequently Asked Questions
What is Clover Biopharmaceuticals Ltd(HKSE:02197)'s stock price today?
The current price of HKSE:02197 is HK$0.45. The 52 week high of HKSE:02197 is HK$1.81 and 52 week low is HK$0.30.
When is next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197)?
The next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197) is 2024-08-23 Est..
Does Clover Biopharmaceuticals Ltd(HKSE:02197) pay dividends? If so, how much?
Clover Biopharmaceuticals Ltd(HKSE:02197) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers